These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
206 related items for PubMed ID: 27050162
21. Effects of antifungal agents alone and in combination against Candida glabrata strains susceptible or resistant to fluconazole. Alves IA, Bandeira LA, Mario DA, Denardi LB, Neves LV, Santurio JM, Alves SH. Mycopathologia; 2012 Sep; 174(3):215-21. PubMed ID: 22528740 [Abstract] [Full Text] [Related]
22. In vitro activity of essential oils extracted from condiments against fluconazole-resistant and -sensitive Candida glabrata. Soares IH, Loreto ÉS, Rossato L, Mario DN, Venturini TP, Baldissera F, Santurio JM, Alves SH. J Mycol Med; 2015 Sep; 25(3):213-7. PubMed ID: 26281965 [Abstract] [Full Text] [Related]
23. Anticandidal synergistic activity of Ocimum sanctum and fluconazole of azole resistance strains of clinical isolates. Zaidi KU, Shah F, Parmar R, Thawani V. J Mycol Med; 2018 Jun; 28(2):289-293. PubMed ID: 29730129 [Abstract] [Full Text] [Related]
24. Synergistic Effect of the Combination of Deferoxamine and Fluconazole In Vitro and In Vivo against Fluconazole-Resistant Candida Spp. An L, Tan J, Wang Y, Liu S, Li Y, Yang L. Antimicrob Agents Chemother; 2022 Nov 15; 66(11):e0072522. PubMed ID: 36286552 [Abstract] [Full Text] [Related]
25. In vitro synergy with fluconazole plus doxycycline or tigecycline against clinical Candida glabrata isolates. Hooper RW, Ashcraft DS, Pankey GA. Med Mycol; 2019 Jan 01; 57(1):122-126. PubMed ID: 29618039 [Abstract] [Full Text] [Related]
26. [The comparison of susceptibility of Candida albicans and Candida glabrata to miconazole]. Kurnatowski P, Makieło L, Horwatt-Bozyczko E. Wiad Parazytol; 2001 Jan 01; 47(4):867-73. PubMed ID: 16886440 [Abstract] [Full Text] [Related]
27. Synergistic mutual potentiation of antifungal activity of Zuccagnia punctata Cav. and Larrea nitida Cav. extracts in clinical isolates of Candida albicans and Candida glabrata. Butassi E, Svetaz LA, Ivancovich JJ, Feresin GE, Tapia A, Zacchino SA. Phytomedicine; 2015 Jun 01; 22(6):666-78. PubMed ID: 26055132 [Abstract] [Full Text] [Related]
28. Detection of fluconazole-resistant isolates of Candida glabrata by using an agar screen assay. Nelson SM, Cartwright CP. J Clin Microbiol; 2003 May 01; 41(5):2141-3. PubMed ID: 12734262 [Abstract] [Full Text] [Related]
29. Antifungal activity and cytotoxicity of extracts and triterpenoid saponins obtained from the aerial parts of Anagallis arvensis L. Soberón JR, Sgariglia MA, Pastoriza AC, Soruco EM, Jäger SN, Labadie GR, Sampietro DA, Vattuone MA. J Ethnopharmacol; 2017 May 05; 203():233-240. PubMed ID: 28389355 [Abstract] [Full Text] [Related]
30. Antifungal effect of Echinophora platyloba on expression of CDR1 and CDR2 genes in fluconazole-resistant Candida albicans. Khajeh E, Hosseini Shokouh SJ, Rajabibazl M, Roudbary M, Rafiei S, Aslani P, Farahnejad Z. Br J Biomed Sci; 2016 May 05; 73(1):44-8. PubMed ID: 27182677 [Abstract] [Full Text] [Related]
31. In vitro activities of anidulafungin against more than 2,500 clinical isolates of Candida spp., including 315 isolates resistant to fluconazole. Pfaller MA, Boyken L, Hollis RJ, Messer SA, Tendolkar S, Diekema DJ. J Clin Microbiol; 2005 Nov 05; 43(11):5425-7. PubMed ID: 16272464 [Abstract] [Full Text] [Related]
32. In vitro interaction of posaconazole and caspofungin against clinical isolates of Candida glabrata. Oliveira ER, Fothergill AW, Kirkpatrick WR, Coco BJ, Patterson TF, Redding SW. Antimicrob Agents Chemother; 2005 Aug 05; 49(8):3544-5. PubMed ID: 16048980 [Abstract] [Full Text] [Related]
33. Activities of micafungin against 315 invasive clinical isolates of fluconazole-resistant Candida spp. Messer SA, Diekema DJ, Boyken L, Tendolkar S, Hollis RJ, Pfaller MA. J Clin Microbiol; 2006 Feb 05; 44(2):324-6. PubMed ID: 16455878 [Abstract] [Full Text] [Related]
34. MALDI-TOF typing highlights geographical and fluconazole resistance clusters in Candida glabrata. Dhieb C, Normand AC, Al-Yasiri M, Chaker E, El Euch D, Vranckx K, Hendrickx M, Sadfi N, Piarroux R, Ranque S. Med Mycol; 2015 Jun 05; 53(5):462-9. PubMed ID: 25841053 [Abstract] [Full Text] [Related]
35. Histone deacetylase inhibitors for enhancing activity of antifungal agent: a patent evaluation of WO2014041424(A1). Zhang L, Xu W. Expert Opin Ther Pat; 2015 Feb 05; 25(2):237-40. PubMed ID: 25381141 [Abstract] [Full Text] [Related]
37. Synergistic antifungal activity of berberine derivative B-7b and fluconazole. Li LP, Liu W, Liu H, Zhu F, Zhang DZ, Shen H, Xu Z, Qi YP, Zhang SQ, Chen SM, He LJ, Cao XJ, Huang X, Zhang JD, Yan L, An MM, Jiang YY. PLoS One; 2015 Jun 05; 10(5):e0126393. PubMed ID: 25992630 [Abstract] [Full Text] [Related]
38. In vitro activity of a Hos2 deacetylase inhibitor, MGCD290, in combination with echinocandins against echinocandin-resistant Candida species. Pfaller MA, Rhomberg PR, Messer SA, Castanheira M. Diagn Microbiol Infect Dis; 2015 Apr 05; 81(4):259-63. PubMed ID: 25600842 [Abstract] [Full Text] [Related]
39. Doxorubicin selects for fluconazole-resistant petite mutants in Candida glabrata isolates. Schulz B, Knobloch M, Weber K, Ruhnke M. Int J Med Microbiol; 2012 Jul 05; 302(3):155-61. PubMed ID: 22664377 [Abstract] [Full Text] [Related]
40. Antimicrobial activity of Buchenavia tetraphylla against Candida albicans strains isolated from vaginal secretions. Cavalcanti Filho JR, Silva TF, Nobre WQ, Oliveira de Souza LI, Silva E Silva Figueiredo CS, Figueiredo RC, de Gusmão NB, Silva MV, Nascimento da Silva LC, Correia MT. Pharm Biol; 2017 Dec 05; 55(1):1521-1527. PubMed ID: 28376640 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]